6Sause W, Kolesar P, Taylor S IV, et al. Final result s of phase Ⅲ trial in regionally advanced unrespectable non - small cell lung cancer: Radiation Therapy Oncology Group , Eastern Cooperatives Oncology Group, and Southwest Oncology Group. Chest, 2000 , 117 (2) :358-364.
7Allen J, Jahanzeb M, J NatlCompr,et al. Neoadjuvant chemotherapy in stage Ⅲ NSCLC. 2008 Mar, 6(3) :285 -93.
8Chen M, Liang GL, Fu XL, et al. The impact of overall treatment time on outcomes in radiation therapy for non small cell lung cancer. Lung Cancer, 2000, (25) : 112 - 19.
9Berghmans T, Paesmans M, Meert A P, et al. Survival improvement in resectable non small cell lung cancer with (neo) adjuvant chemotherapy : result s of a meta analysis of the literature. Lung Cancer, 2005, 49 (1):13-23.
10Ferrigno D, Buccheri G, et al. Second line chemotherapy for recurrent non small cell lung Cancer: do new agents make a difference. Lung Cancer, 2000, 29:91.
2Ramos R,Masuet C,Gossot D.Lobectomy for early stage lung carcinoma:a cost analysisi of full thporacoscopy versus posterplateral thoracotomy[J].Surg Endosc,2012(26):431-437.
3Jiang G,Yang F,Li X,et al.Viedo assisted thoracoscopic surgery is more favorable than thoracotomy for administration of adjuvant chemotherapy after lobectomy for non small cell lung cancer[J].World J Surg Oncol,2011(9):170.
4Berry MF,Villamizar Ortiz,Tong BC,et al.Pumonary function tests do not predict pulmonary complications after thoracoscopie lobectomy[J].Ann Thorac Surg,2010,89(4):1044-1051.
